GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Czech National Bank

Czech National Bank increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 6.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 105,034 shares of the company's stock after acquiring an additional 5,974 shares during the period. Czech National Bank's holdings in GE HealthCare Technologies were worth $8,477,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. JPMorgan Chase & Co. increased its position in GE HealthCare Technologies by 29.8% during the third quarter. JPMorgan Chase & Co. now owns 2,233,603 shares of the company's stock valued at $209,624,000 after acquiring an additional 512,778 shares during the last quarter. Blue Trust Inc. raised its position in GE HealthCare Technologies by 21.4% in the 4th quarter. Blue Trust Inc. now owns 2,834 shares of the company's stock worth $222,000 after purchasing an additional 500 shares during the period. Robeco Institutional Asset Management B.V. lifted its stake in GE HealthCare Technologies by 62.1% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 57,445 shares of the company's stock worth $4,491,000 after purchasing an additional 21,997 shares during the last quarter. Heck Capital Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $118,000. Finally, Chicago Partners Investment Group LLC grew its stake in shares of GE HealthCare Technologies by 6.4% during the fourth quarter. Chicago Partners Investment Group LLC now owns 5,280 shares of the company's stock valued at $455,000 after buying an additional 319 shares during the last quarter. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Up 0.6%

GE HealthCare Technologies stock traded up $0.42 during trading hours on Thursday, reaching $71.55. The stock had a trading volume of 1,864,761 shares, compared to its average volume of 3,437,854. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a market cap of $32.76 billion, a price-to-earnings ratio of 16.52, a PEG ratio of 3.19 and a beta of 1.21. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The business's 50 day moving average price is $68.35 and its 200-day moving average price is $78.84.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, beating analysts' consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $4.78 billion during the quarter, compared to analysts' expectations of $4.66 billion. During the same quarter in the prior year, the company posted $0.90 earnings per share. GE HealthCare Technologies's revenue for the quarter was up 2.7% compared to the same quarter last year. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies announced that its Board of Directors has authorized a share buyback program on Wednesday, April 30th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 3.1% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its shares are undervalued.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.20%. The ex-dividend date was Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is currently 2.95%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on GEHC shares. The Goldman Sachs Group dropped their price objective on GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Wall Street Zen upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Morgan Stanley decreased their price objective on shares of GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Wells Fargo & Company lowered their price objective on shares of GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating for the company in a research report on Thursday, May 1st. Finally, Citigroup reduced their target price on shares of GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a research report on Wednesday, April 30th. Three investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $88.27.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.